Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Effectiveness of Self-Help for Dually-Diagnosed Persons - 1

This study has been completed.
Sponsor:
Collaborator:
National Development and Research Institutes, Inc.
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00218582
First received: September 20, 2005
Last updated: January 11, 2017
Last verified: October 2008
  Purpose
The purpose of this study is to determine the effectiveness of adding dual focus 12-step self-help groups to standard treatment to improve behavioral outcomes for patients dually diagnosed with substance abuse and psychiatric disorders.

Condition Intervention Phase
Dual Diagnosis
Substance-Related Disorders
Mental Disorders
Behavioral: Double Trouble in Recovery
Behavioral: Standard psychiatric day treatment
Phase 1
Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effectiveness of Self-Help for Dually-Diagnosed Persons

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • drug/alcohol use [ Time Frame: past 90 days ]

Secondary Outcome Measures:
  • psychiatric medication adherence [ Time Frame: recent ]
  • traditional 12 step meeting attendance [ Time Frame: past 90 days ]
  • psychiatric symptoms [ Time Frame: recent ]
  • program retention [ Time Frame: up to 6 months ]

Enrollment: 229
Study Start Date: March 2003
Study Completion Date: March 2007
Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Dual focus 12 step mutual aid groups for persons with co-occurring disorders (psychiatric and substance use disorders), provided within the context of standard psychiatric day treatment
Behavioral: Double Trouble in Recovery
Dual focus 12 step mutual aid groups for persons with co-occurring disorders (psychiatric and substance use disorders), provided within the context of standard psychiatric day treatment
Active Comparator: 2
Standard psychiatric day treatment
Behavioral: Standard psychiatric day treatment
Individual counseling, groups, medication

  Eligibility

Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Admission to psychiatric day treatment program 18-64 years old

Exclusion Criteria:

Did not understand or speak English, appeared intoxicated on drugs or alcohol, carried a diagnosis of mental retardation, were deemed actively psychotic by the clinic's intake coordinator, appeared unable to understand and give informed consent.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00218582

Locations
United States, New York
Albert Einstein Dept of Psychiatry
Bronx, New York, United States, 10461
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
National Development and Research Institutes, Inc.
Investigators
Principal Investigator: Stephen Magura, Ph.D. National Development and Research Institutes, Inc.
  More Information

Publications:
Responsible Party: Stephen Magura, Western Michigan University
ClinicalTrials.gov Identifier: NCT00218582     History of Changes
Other Study ID Numbers: NIDA-15912-1
R01-15912-1
Study First Received: September 20, 2005
Last Updated: January 11, 2017

Keywords provided by National Institute on Drug Abuse (NIDA):
12 step groups
self help
psychiatric day treatment
co-occurring disorders
dual diagnosis

Additional relevant MeSH terms:
Disease
Substance-Related Disorders
Mental Disorders
Psychotic Disorders
Pathologic Processes
Chemically-Induced Disorders
Schizophrenia Spectrum and Other Psychotic Disorders

ClinicalTrials.gov processed this record on April 27, 2017